Walking the Isobole of Drug Interaction: Comparison of Hemodynamic Effects, Cerebral and Tissue Oxygenation for 4 Equipotent Combinations of Propofol and Remifentanil
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 87
- 试验地点
- 1
- 主要终点
- Blood pressure
研究概览
简要总结
The investigators study whether four equipotent combinations of propofol and remifentanil (as predicted by interaction models for "tolerance of laryngoscopy") result in identical haemodynamic conditions, independent of their relative different balance between the concentration of propofol and remifentanil.
详细描述
In anesthesia, the synergistic interaction between hypnotics and opioids is applied daily to give adequate anesthesia and analgesia at significantly lower doses compared with the ones needed if only one drug was given to reach the same effect. A lot of research has been done to quantify these interactions with a focus on the desired effects (Tolerance of laryngoscopy, tolerance of shake and shout etc...), but the simultaneous interaction on the unwanted side effects is less well described. The response surface model of Bouillon et al. and other models predict combinations of propofol and remifentanil effect-site concentrations that lead to an equipotent desired effect. Due to the availability of the models, the anesthesiologists now could use the knowledge on interactions to target specific effects more accurately, using predefined equipotent combinations of drugs: for instance, a desirable 90% probability of tolerance of laryngoscopy (TOL90) in the population can be reached through either a high propofol/low remifentanil combination, but equally well through a low propofol-high remifentanil combination.
However, at this time it is not known whether some of the combinations of propofol and remifentanil have a favorable hemodynamic stability compared to other equipotent combinations. The researcher in this study want to determine whether equipotent combinations of remifentanil and propofol (all deliberately selected to evoke 90% probability of "tolerance to laryngoscopy"), result in different effects on the undesired side effects of anesthetics, such as hemodynamic instability (hypotension, changes in heart rate or cardiac output), decreases in cerebral or tissue oxygenation (both measured with near infrared spectroscopy).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Written informed consent
- •General anesthesia required for the procedure
- •Age: 18 years and older
- •American Society of Anesthesiologists (ASA) physical status I to III
排除标准
- •Refusal to participate in this study
- •Contra-indications for the use of propofol or remifentanil
- •BMI > 35 kg/m2
- •Central nervous system disorders (i.e. cerebrovascular accident, dementia, seizures, psychiatric disorders)
- •Relevant hepatic disease (Child B or higher)
- •Regular use of medication that affects the central nervous system (i.e. benzodiazepines, antidepressants, antipsychotics, antiepileptic drugs)
- •Use of alpha-agonists or beta-blockers
- •Overt signs of alcohol abuse
- •Use of preoperative benzodiazepines (on the day of the study)
- •Beta blockers eye drips
- •Overt signs of Drugs abuse
研究组 & 干预措施
Group A propofol + remifentanil
Propofol highest dose, remifentanil lowest dose, TOL 90% according to Bouillon model
干预措施: Group A propofol + remifentanil (Drug)
Group B propofol + remifentanil
Propofol intermediate high, remifentanil intermediate low, TOL90% according to the Bouillon Model
干预措施: Group B propofol + remifentanil (Drug)
Group C propofol + remifentanil
propofol intermediate low+ remifentanil intermediate high: TOL 90% according to the Bouillon interaction model
干预措施: Group C propofol + remifentanil (Drug)
group D propofol + remifentanil
propofol lowest dose+ remifentanil highest dose: TOL 90% according to the Bouillon model
干预措施: group D propofol + remifentanil (Drug)
结局指标
主要结局
Blood pressure
时间窗: From start drug till intubation which will take on average 15 minutes of measurement
Continuously stored on a laptop (systolic, diastolic and mean blood pressure over time) using a Philips Non Invasive Blood Pressure measurements every minute and a Nexfin monitor (continuous non invasive blood pressure measurement)
次要结局
- Electro Encephalographic derived indices of anesthetic depth(From start first drug till intubation, which will take on average 15 minutes of measurement)
- Heart rate(From start first drug till intubation, which will take on average 15 minutes of measurement)
- Cerebral and tissue oxygenation(From start drug till intubation, which will take on average 15 minutes of measurement)
- Probability of tolerance to laryngoscopy(one minute before laryngoscopy till three minutes after)
- Cardiac index(From start first drug till intubation, which will take on average 15 minutes of measurement)
研究者
Hugo E.M.Vereecke
Dr.
University Medical Center Groningen
